Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Glenmark Signs Exclusive Deal for Generic Softgel Capsules

By Glenmark Pharmaceuticals | July 19, 2017

Glenmark Pharmaceuticals enters exclusive agreement with Cyndea Pharma S.L. for generic soft-gelatin capsule drug products.

Glenmark Pharmaceuticals, a global pharmaceutical company, announced it has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma S.L., granting exclusive rights to use their technology for developing generic, soft-gelatin capsule formulations of certain pharmaceutical products. 

“As many as 70 percent of small molecule pharmaceuticals are difficult for the body to absorb, which leads to challenges in developing effective oral formulations for these medicines,”1 said Robert Matsuk, president, North America, Global API at Glenmark Pharmaceuticals. “Because of these challenges, the use of soft-gelatin capsules have wide applications to improve absorption and bioavailability of these medicines. Accessing this formulation and manufacturing technology with our strategic partner Cyndea will support Glenmark’s continued mission of providing important and cost-effective generic medicines to patients.”

Under this agreement, Glenmark receives exclusive rights to the United States and Canada markets for these soft-gelatin formulations in exchange for sharing development costs and profits from future sales. In addition, the agreement provides for the companies to add further soft-gelatin product candidates for development and commercialization, as new branded, soft-gelatin, capsule-based drug products become available in the marketplace.

“Glenmark is an ideal partner to expand our soft-gelatin technology into much needed therapeutic categories and markets,” said Gonzalo Ballesteros, managing director of Cyndea. “Cyndea has made significant financial investments in both its new Madrid-based research and development facility and state-of-the-art production facility located in Soria, Spain. Cyndea is a global, market-leading supplier of generic, prescription, soft-gelatin capsules in the world and our partnership with Glenmark provides expanded access into North America.” 

Cyndea Pharma specializes in the development and manufacturing of Women’s Health Care and niche products using differentiated technologies to deliver value added products to its customers. It supports partners in more than 90 countries. 

Glenmark Pharmaceuticals Ltd. is a global pharmaceutical company with operations in more than 50 countries. Glenmark has a diverse pipeline with several compounds in various stages of clinical development, primarily focused in the areas of oncology, respiratory disease, and dermatology.
______________________________________________________

Reference:

1 “Bioavailability & Solubility.” Drug Development & Delivery. March 2015. http://www.drug-dev.com/Main/Back-Issues/SPECIAL-FEATURE-Bioavailability-Solubility-A-Deman-875.aspx. Last accessed June 21, 2017.

(Source: PR Newswire)

Related Articles Read More >

Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Prolific Machines logo.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE